Editas Medicine Appoints Cynthia Collins President & CEO

Cynthia Collins has been appointed president and CEO of Editas Medicine (NASDAQ: EDIT). Collins has been serving as interim CEO of the Cambridge, MA, company since Katrine Bosley left the chief executive role in March. Collins will continue to serve on the Editas board of directors. Her experience includes executive roles at Human Longevity, the healthcare and life sciences business of General Electric (NYSE: GE), Clarient Diagnostics, GenVec, and Beckman Coulter (NYSE: BEC).